Buy, hold, or sell? Bubs, Soul Patts, and Endeavour shares

Experts have reviewed their ratings on these ASX shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are down 0.07% to 8,945.5 points on Thursday.

Meantime, brokers have reviewed their ratings and 12-month share price targets on three ASX shares.

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.

Image source: Getty Images

Bubs Australia Ltd (ASX: BUB)

The Bubs share price is steady at 11 cents, and down 12.5% over 12 months.

This week, Shaw & Partners gave the ASX consumer staples share a buy rating.

The broker said its DCF valuation remained 18 cents per share following the company's 2026 Strategy Day.

We are particularly impressed by BUB's success in the USA.

Having only entered the USA in 2022 under the FDA's enforcement discretion, US distribution is expected to reach circa 10,000 doors by end 2026, up over 100% on 2025.

Given that Kendamil only recently received permanent FDA approval, we expect BUB's permanent approval to come through shortly. 

BUB re-iterated its FY26 guidance for Revenue of $120-125m and reported EBITDA of $4- 6m.

Our forecasts remain $121.5m and $4.5m, respectively.

Washington H. Soul Pattinson and Co Ltd (ASX: SOL)

Soul Patts shares are $43.26, up 0.7% today, and up 23.8% over 12 months.

Morgans maintains a hold rating on this ASX financial share following its 1H FY26 report.

The diversified investment group reported statutory net profit after tax (NPAT) of $2,303 million, up 604.3%.

The extraordinary increase reflected the Brickworks merger, the sell-down of Tuas Ltd (ASX: TUA) and Aeris Resources Ltd (ASX: AIS) shares, and a realised gain from the sale of Apex Healthcare.

Underlying regular NPAT increased 6.7% to $304 million.

The pre-tax net asset value (NAV) climbed 14.6% to $13.8 billion, and the portfolio generated a 9.7% return for the first half.

Soul Patts increased its interim dividend by 9.1% to 48 cents per share, fully franked.

Morgans commented:

We continue to like the SOL story, particularly its track record of growing distributions and history of uncorrelated and above market returns.

Endeavour Group Ltd (ASX: EDV)

Endeavour shares are $3.28, down 0.2% today, and down 16.2% over 12 months.

The Endeavour share price fell to a record low of $3.13 on Tuesday.

On The Bull this week, Mark Elzayed from Investor Pulse revealed a sell rating on Endeavour shares.

In our view, key concerns emerged in its first half result in fiscal year 2026.

Underlying group earnings before interest and tax of $563 million fell 5.4 per cent despite a 0.9 per cent increase in group sales to $6.7 billion.

While the hotels segment generated a 4.4 per cent increase in sales, the retail division, comprising Dan Murphy's and BWS, posted a 11.6 per cent decline in underlying EBIT.

Statutory net profit after tax fell 17.1 per cent to $247 million, impacted by $45 million in significant items.

Downward revisions in consensus earnings per share suggest the bottom may not have been reached at this point.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy Capstone Copper shares today

A leading analyst expects more outperformance from Capstone Copper’s surging shares. But why?

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Broker Notes

What is this broker's view on Magellan Financial Group after yesterday's disappointing results

Where to next for this funds manager?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

This ASX industrials stock could be set to double according to one broker

This ASX small-cap could be one to keep an eye on.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Broker Notes

What's Bell Potter's updated view on CSL shares?

Will the new tariffs impact CSL according to Bell Potter?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares

The team at Morgans has given its verdict on these popular shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Morgans names two ASX 200 shares to buy and one to sell this week

Let's see which shares Morgans is bullish and bearish on this week.

Read more »